It’s been nearly two decades since medical science has produced a new treatment for Alzheimer’s. Is that drought about to end?
June 7 will be a big day in the life of Jeff Borghoff — not to mention the more than 6 million other Americans living with Alzheimer’s disease.
On that date, the U.S. Food and Drug Administration is expected to announce whether it will give its blessing to the first new drug for the treatment of Alzheimer’s since 2003.
Borghoff fervently hopes the answer is yes. The 57-year-old resident of Forked River has been taking the drug for several years now, and he’s convinced it has helped significantly slow the progression of his dementia.